| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Robert D Odze | |
| Stuart Jon Spechler | |||
| Nathan A Gray | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 | ||
| Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial | Q28293803 | ||
| Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? | Q30757142 | ||
| Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus | Q30846840 | ||
| Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus | Q30929194 | ||
| Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial | Q30942884 | ||
| Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus | Q31039245 | ||
| Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients | Q31943624 | ||
| Photodynamic therapy in Barrett's esophagus | Q32061991 | ||
| The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy | Q32098156 | ||
| Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid | Q32100250 | ||
| Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results | Q33187809 | ||
| 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial | Q33202826 | ||
| Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. | Q33210093 | ||
| Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness | Q33222183 | ||
| Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer | Q33228918 | ||
| Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy | Q33320089 | ||
| History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus | Q33786336 | ||
| Radiofrequency ablation of Barrett's esophagus: short-term results | Q34927528 | ||
| Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus | Q34979240 | ||
| Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia | Q34992275 | ||
| Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus | Q35920793 | ||
| Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. | Q36815650 | ||
| Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry | Q37114959 | ||
| Endoscopic work-up of early Barrett's neoplasia | Q37344267 | ||
| Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus | Q37495646 | ||
| Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management | Q37531353 | ||
| Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation | Q37587808 | ||
| Does ablative therapy for Barrett esophagus affect the depth of subsequent esophageal biopsy as compared with controls? | Q37756490 | ||
| Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. | Q42493566 | ||
| Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation | Q43086003 | ||
| Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus | Q44918411 | ||
| Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer | Q45166040 | ||
| Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia | Q46256609 | ||
| Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. | Q46448485 | ||
| Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia | Q46461376 | ||
| A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). | Q46610278 | ||
| Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia | Q46881961 | ||
| Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. | Q47693702 | ||
| Squamous islands in Barrett's esophagus: what lies underneath? | Q50525032 | ||
| Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. | Q51079668 | ||
| Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus? | Q53088837 | ||
| Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus | Q77300921 | ||
| Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma | Q78540342 | ||
| Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy | Q79838344 | ||
| Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities | Q80190188 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients | Q81313994 | ||
| Stem cells in Barrett's esophagus: HALOs or horns? | Q81517143 | ||
| Biomarkers and photodynamic therapy for Barrett's esophagus: time to FISH or cut bait? | Q81624634 | ||
| Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry | Q82852832 | ||
| Circumferential and focal ablation of Barrett's esophagus containing dysplasia | Q83251993 | ||
| Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm | Q83365261 | ||
| Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma | Q83761394 | ||
| Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia | Q83982914 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Barrett's esophagus | Q808892 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 1899-908; quiz 1909 | |
| P577 | publication date | 2011-08-09 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review | |
| P478 | volume | 106 |
| Q41702557 | A nonrandomized trial of vitamin D supplementation for Barrett's esophagus. |
| Q37653058 | A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma |
| Q40365358 | ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus |
| Q57107615 | Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells |
| Q26781194 | Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma |
| Q27332349 | BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia |
| Q95488201 | Barrett oesophagus |
| Q36803517 | Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists |
| Q26751171 | Barrett's esophagus in 2016: From pathophysiology to treatment |
| Q34380645 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus |
| Q84441244 | Buried (but not dead) Barrett's metaplasia: tales from the crypts |
| Q57297316 | Buried Barrett's Esophagus with High-Grade Dysplasia after Radiofrequency Ablation |
| Q89209992 | Buried Barrett's Esophagus-a Sheep in Sheep's Clothing |
| Q36093101 | Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos). |
| Q34933881 | Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation. |
| Q41374462 | Comparative diagnostic performance of volumetric laser endomicroscopy and confocal laser endomicroscopy in the detection of dysplasia associated with Barrett's esophagus |
| Q38852845 | Current Controversies in Radiofrequency Ablation Therapy for Barrett's Esophagus. |
| Q37523763 | Depth-resolved imaging of colon tumor using optical coherence tomography and fluorescence laminar optical tomography |
| Q41018709 | Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus |
| Q47848689 | Developments in optical imaging for gastrointestinal surgery. |
| Q37055792 | Diagnosis and management of Barrett's esophagus |
| Q41550041 | Diagnosis and management of Barrett's metaplasia: What's new |
| Q47263224 | Endoscopic Eradication Therapy in Barrett's Esophagus |
| Q38203508 | Endoscopic Optical Coherence Tomography (OCT): Advances in Gastrointestinal Imaging |
| Q38919329 | Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer |
| Q53045453 | Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma. |
| Q42157795 | Endoscopic mucosal resection of Barrett's esophagus detects high prevalence of subsquamous intestinal metaplasia |
| Q38014493 | Endoscopic therapies for Barrett's-associated dysplasia: a new paradigm for a new decade |
| Q38001289 | Endotherapy for Barrett's esophagus |
| Q35625747 | Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia |
| Q37997343 | High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of endoscopic eradication therapy |
| Q96304872 | Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma |
| Q92134302 | Inflammatory bowel disease- and Barrett's esophagus-associated neoplasia: the old, the new, and the persistent struggles |
| Q28602175 | Label-free multi-photon imaging of dysplasia in Barrett's esophagus |
| Q38284790 | Limitations of endoscopic ablation in Barrett's esophagus |
| Q33628118 | Low grade dysplasia in Barrett's esophagus: Should we worry? |
| Q38111974 | Management controversies in Barrett's oesophagus |
| Q92485215 | Management of Barrett Esophagus Following Radiofrequency Ablation |
| Q38150209 | Management of early-stage esophageal neoplasia (MESEN) consensus |
| Q38062526 | Management strategies of Barrett's esophagus |
| Q37609156 | Managing Barrett's esophagus with radiofrequency ablation |
| Q38051702 | Molecular biomarkers and ablative therapies for Barrett's esophagus |
| Q38366775 | Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). |
| Q57171968 | Natural History of the Post-ablation Esophagus |
| Q42138051 | Non-radical, stepwise complete endoscopic resection of Barrett's epithelium in short segment Barrett's esophagus has a low stricture rate |
| Q26751330 | Post-ablation surveillance in Barrett's esophagus: A review of the literature |
| Q89112258 | Radiofrequency ablation devices |
| Q35630291 | Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location |
| Q89205553 | Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trial |
| Q34418909 | Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation |
| Q38485909 | Systematic review: the prevention of oesophageal stricture after endoscopic resection. |
| Q38210245 | The changing role of the pathologist in the management of Barrett's oesophagus |
| Q36195501 | The cost effectiveness of radiofrequency ablation for Barrett's esophagus. |
| Q40449837 | The evil lies below the surface: Subsquamous tumor extension in Barrett's adenocarcinoma. |
| Q41202627 | The impact of flexible endoscopy in esophageal surgery |
| Q37591983 | Treatment of dysplasia in barrett esophagus |
| Q64085011 | Treatment of high-grade dysplasia and intramucosal carcinoma using radiofrequency ablation or endoscopic mucosal resection + radiofrequency ablation: Meta-analysis and systematic review |
| Q91626956 | Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry |
| Q27332535 | Volumetric laser endomicroscopy detects subsquamous Barrett's adenocarcinoma |
| Q55426802 | microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review. |
Search more.